Biohaven Ltd (BHVN)
41.19
+0.50
(+1.23%)
USD |
NYSE |
May 06, 16:00
41.23
+0.04
(+0.10%)
Pre-Market: 20:00
Biohaven Price: 41.19 for May 6, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 06, 2024 | 40.55 | 41.29 | 40.10 | 41.19 | 498524.0 |
May 03, 2024 | 40.72 | 42.10 | 40.45 | 40.69 | 789387.0 |
May 02, 2024 | 40.18 | 40.94 | 39.21 | 39.90 | 797706.0 |
May 01, 2024 | 38.60 | 41.64 | 38.42 | 40.18 | 1.642M |
Apr 30, 2024 | 39.80 | 40.28 | 38.29 | 38.80 | 1.080M |
Apr 29, 2024 | 39.30 | 40.15 | 38.54 | 39.83 | 1.250M |
Apr 26, 2024 | 38.61 | 39.28 | 37.75 | 38.97 | 948357.0 |
Apr 25, 2024 | 38.95 | 38.95 | 36.77 | 38.54 | 1.851M |
Apr 24, 2024 | 40.19 | 40.62 | 38.38 | 38.72 | 971893.0 |
Apr 23, 2024 | 40.54 | 41.88 | 39.25 | 39.61 | 2.087M |
Apr 22, 2024 | 39.70 | 39.70 | 38.19 | 38.33 | 1.132M |
Apr 19, 2024 | 42.36 | 43.24 | 37.61 | 38.99 | 3.353M |
Apr 18, 2024 | 42.90 | 43.31 | 41.00 | 42.16 | 3.668M |
Apr 17, 2024 | 44.14 | 45.60 | 42.54 | 44.03 | 1.040M |
Apr 16, 2024 | 44.77 | 45.07 | 42.34 | 43.77 | 1.955M |
Apr 15, 2024 | 50.96 | 52.50 | 43.58 | 44.77 | 3.402M |
Apr 12, 2024 | 53.49 | 53.70 | 52.12 | 53.08 | 792385.0 |
Apr 11, 2024 | 51.53 | 53.80 | 51.20 | 53.49 | 697997.0 |
Apr 10, 2024 | 50.37 | 51.60 | 49.77 | 51.06 | 718485.0 |
Apr 09, 2024 | 51.62 | 53.13 | 50.85 | 51.98 | 756411.0 |
Apr 08, 2024 | 52.29 | 52.42 | 50.02 | 51.41 | 834721.0 |
Apr 05, 2024 | 51.93 | 53.73 | 51.36 | 52.52 | 584172.0 |
Apr 04, 2024 | 52.70 | 55.72 | 51.60 | 52.33 | 879794.0 |
Apr 03, 2024 | 50.25 | 52.74 | 50.25 | 52.28 | 934434.0 |
Apr 02, 2024 | 50.99 | 52.15 | 50.10 | 50.79 | 1.230M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.30
Minimum
Sep 30 2022
59.75
Maximum
Mar 13 2024
25.73
Average
19.56
Median
Price Benchmarks
Amgen Inc | 299.55 |
Eli Lilly and Co | 766.68 |
Regeneron Pharmaceuticals Inc | 958.64 |
Viking Therapeutics Inc | 78.20 |
Alnylam Pharmaceuticals Inc | 151.24 |
Price Related Metrics
Price to Book Value | 7.859 |
Earnings Yield | -13.89% |
Market Cap | 3.364B |